High Pressure Contrast Media Injectors Market Size - By Product (Injector Systems, Consumables), By Type (Single Head Injectors, Dual Head Injectors, Syringeless Injectors), By Application, By End-use – Global Forecast to 2032

High Pressure Contrast Media Injectors Market Size

High Pressure Contrast Media Injectors Market size was valued at USD 176.4 million in 2022 and is estimated to account for USD 551.1 million by 2032. High-pressure contrast media injectors, also known as high-pressure syringe injectors or power injectors are medical devices used in radiology procedures to administer contrast media into the patient's body.
 

Contrast media are substances that enhance the visibility of anatomical structures or blood vessels during imaging studies such as computed tomography (CT) scans, angiography, or magnetic resonance imaging (MRI). Increasing prevalence of numerous diseases such as cancer, neurological and cardiovascular diseases that require diagnostic imaging procedures will contribute to the demand for high pressure contrast media injectors. Additionally, technological advancements in imaging agents and the need for accurate and detailed diagnostic information.

Moreover, technological advancements in medical imaging modalities such as CT scans, angiography, and MRI. These advancements enable more precise and detailed imaging requiring efficient and high-pressure injectors to deliver contrast media effectively, thereby positively influencing product demand. Furthermore, rising demand for real time imaging and contrast-enhanced imaging in the diagnostic procedure to improve image quality, including higher resolution, faster acquisition time, and reduced artifacts.

COVID-19 Impact

The COVID-19 pandemic had negatively impacted the high pressure contrast media injectors market.  The adverse impact is owing to disruptions in non-urgent or elective procedures, including imaging studies that require contrast-enhanced imaging. Moreover, clinical facilities focused on managing COVID-19 patients and prioritized urgent and critical procedures that led to a decline in the number of contrast-enhanced imaging procedures. This has resulted in a temporary decrease in the demand for high-pressure contrast media injectors. Restrictions on international trade, factory shutdowns, and transportation disruptions led to delays in the production and delivery of these devices.
 

High Pressure Contrast Media Injectors Market Trends

Increasing prevalence rate of several chronic diseases including cancer, cardiovascular and neurological disorders across the globe is major factor accelerating the industry.  For instance, as per the International Agency for Research on Cancer (IARC), it is estimated that more than 27.5 million new patients will suffer from cancer worldwide by the year 2040.
 

Additionally, according to the World Health Organization (WHO) estimates, cancer is the one of the leading causes of death in majority of countries globally.  This prediction is primarily based on increase in aging population and rising incidence of risk factors such as smoking, unhealthy lifestyle and among others in various regions of the world. Similarly, according to the World Heart Federation, globally, more than half a billion individuals associated with cardiovascular diseases in 2021.
 

High Pressure Contrast Media Injectors Market Analysis

The high pressure contrast media injectors market by product is categorized into injector systems and consumables. Consumables segment is further subdivided into syringes, tubing and others. The consumables segment is predicted to witness significant progression at 11.9% CAGR by 2032. Growing prevalence of chronic diseases and the need for accurate diagnosis and treatment monitoring drive the demand for contrast-enhanced imaging studies. As a result, there is a higher requirement for consumables such as syringes and tubing sets that are essential for delivering contrast media effectively during these procedures. Thus, High demand for consumables in imaging procedures will boost segmental demand. Moreover, rising emphasis on infection control and preventing cross-contamination drives the demand for disposable consumables. Healthcare facilities prefer to use single-use consumables such as syringes, tubing sets and filters to minimize the risk of infections and ensure sterility during contrast media administration.
 

Further, increasing availability of consumables that are equipped with smart technology such as sensors or RFID technology to provide real-time data on usage, expiration dates, and several other benefits will stimulate segmental expansion potential. Also, integration of such technologies enables improved inventory management, better tracking of consumable usage and timely replenishment, optimizing workflow efficiency thereby, accelerating segment adoption rate.
 

Based on type, the high pressure contrast media injectors market is segmented into dual head injectors, single head injectors and syringeless injectors. The single head injectors segment is accounted for over 44% market share in the year 2022. Advancements in medical imaging technologies will drive the demand for the single head injectors. As, imaging technologies continue to improve, the need for advanced single head injectors to deliver contrast media efficiently and precisely will increase substantially. For instance, the integration of single head injectors with advanced imaging modalities like dual-energy CT or functional MRI enables a comprehensive evaluation of certain conditions.
 

The high pressure contrast media injectors market is segmented by application into interventional cardiology, interventional radiology, endovascular surgery and interventional neuroradiology. High segment gains is attributable to increasing prevalence of cardiovascular diseases including coronary artery disease, heart failure and cardiac arrhythmias driving the demand for interventional cardiology procedures such as angiography, angioplasty, and stenting. High-pressure contrast media injectors are essential in these procedures for precise delivery of contrast agents, enhancing visualization of blood vessels and cardiac structures thereby, accelerating market demand.
 

Moreover, growing need for portable and compact high-pressure injectors and development of smaller, lightweight injectors that can be easily transported and used in various clinical settings.
 

The high pressure contrast media injectors market is segmented by end-use into hospitals, diagnostic centers and ambulatory surgical centers. High segment growth is attributable to enhanced diagnostic and interventional procedures coupled with integration of advanced medical imaging equipment among hospital settings. Also, rising adoption and integration of high-pressure injectors with picture archiving and communication systems (PACS) that allows automated image transfer, improved data management, and streamlined workflows, enhancing the overall efficiency and accessibility of imaging services in hospitals.
 

U.S. high pressure contrast media injectors market accounted for USD 62.9 million revenue size in 2022. The U.S. industry gains is owing to increasing prevalence of chronic diseases, advancements in imaging technologies, the shift towards minimally invasive procedures, and the emphasis on patient safety and workflow efficiency. Rising number of people suffering from chronic diseases is a prime factor accelerating market demand.
 

For instance, as per the American Cancer Society, more than 1.9 million new cancer cases were diagnosed in 2022. Moreover, high adoption and integration of advanced imaging technologies among healthcare facilities, increasing healthcare expenditure and favourable reimbursement scenario.
 

High Pressure Contrast Media Injectors Market Share

Some of the major market players operating in the high pressure contrast media injectors market include

• Bracco Group
• Medtron AG
• Guerbet Group
• Bayer HealthCare LLC
• NemotoKyorindo Co., Ltd.
• ulrich GmbH & Co. KG
• GE Healthcare
• Apollo RT Co. Ltd.
• Sino Medical-Device Technology Co.
• VIVID IMAGING 
   

High Pressure Contrast Media Injectors Industry News:

• In November 2022, GE Healthcare announced agreement with ulrich medical aimed at enhancing its market position in the growing U.S. market. As per the agreement, these two companies will co-ordinate to develop and offer multi-dose contrast media injector in the country.
   
• In September 2022, Bracco Diagnostics Inc., a part of Bracco Imaging S.p.A. received approval for its Gadopiclenol Injection by the U.S. FDA. Gadopiclenol Injection consists of highly stable macrocyclic gadolinium-based contrast agent (GBCA) that offers enhanced relaxivity compared to commercial injections in the U.S. This approval strengthened company’s product portfolio in the significant market.
   

High pressure contrast media injectors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product (USD Million & Units)

• Injector systems
• Consumables
  • Syringes
  • Tubing
  • Others

By type (USD Million)

• Single head injectors
• Dual head injectors
• Syringeless injectors

By Application (USD Million)

• Interventional cardiology
• Interventional radiology
• Endovascular surgery
• Interventional neuroradiology

By End-use (USD Million)

• Hospitals
• Diagnostic centers
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey